Here are three updates on gastroenterology companies from the past week:
GI & Endoscopy
Frank Friedenberg, MD, is the gastroenterology section chief at Philadelphia-based Temple University's Lewis Katz School of Medicine.
Chronic idiopathic constipation sufferers may soon find relief with the FDA approval of Shire's prucalopride.
Apollo Endosurgery sold its Lap-Band gastric banding device to ReShape Lifesciences for $17 million and acquired ReShape's intragastric balloon device, MassDevice reports.
Rita Ritsema, MD, will now see patients out of the Havertown, Pa.-based location of Bryn Mawr Medical Specialists Association, the Daily Times reports.
Motus GI Holdings will offer a follow-up to its initial public offering, including a proposed offering of 5,000,000 additional shares.
Vivek Kaul, MD, is the gastroenterology division chief at the University of Rochester (N.Y.) Medical Center.
Here are four GI-driven ASCs and facilities that were opened or announced in November and December 2018:
Atlanta Gastroenterology Associates closed a deal with Frazier Healthcare Partners and formed gastroenterology management company United Digestive Dec. 17.
Los Angeles-based Cedars-Sinai Inflammatory Bowel and Immunobiology Research Institute tapped Jonathan Braun, MD, PhD, to serve as director of enterprise operations.
